Institutional Ownership
Pavmed Inc
CUSIP 70387R502COMPAVMQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
17
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Two Seas Capital LP | 461.5K | $4.68M |
| 2 | First Manhattan Co. LLC. | 23.8K | $241.6K |
| 3 | Geode Capital Management, LLC | 11.8K | $119.5K |
| 4 | Blackrock, Inc. | 2.4K | $24.5K |
| 5 | Tower Research Capital LLC (Trc) | 622 | $6.3K |
| 6 | Morgan Stanley | 165 | $1.7K |
| 7 | Cwm, LLC | 157 | $1.6K |
| 8 | Ubs Group AG | 75 | $760 |
| 9 | Sbi Securities Co., Ltd. | 67 | $680 |
| 10 | Wells Fargo & Company/Mn | 45 | $457 |